Maternal hypoglycaemia on the 50 g oral glucose challenge test — evaluation of obstetric and neonatal outcomes by Budak, Mehmet Şükrü & Araç, Eşref
370
ORGINAL PAPER /  OBSTERICS
Ginekologia Polska
2018, vol. 89, no. 7, 370–374
Copyright © 2018 Via Medica
ISSN 0017–0011
DOI: 10.5603/GP.a2018.0063
Maternal hypoglycaemia on the 50 g oral glucose 
challenge test — evaluation of obstetric and neonatal 
outcomes
Mehmet Şükrü Budak1, Eşref Araç2
1Health Sciences University Diyarbakır Gazi Yaşargil Training and Research Hospital, Department of Obstetrics and Gynecology, 
Diyarbakır, Turkey 
2Health Sciences University, Gazi Yaşargil Education and Research Hospital, Department of Internal Medicine, Diyarbakır, Turkey
ABSTRACT
Objectives: To discuss obstetric and neonatal outcomes of maternal hypoglycaemia observed after the 50 g oral glucose 
challenge test.
Material and methods: A retrospective evaluation was made of the results of patients at 24–28 weeks gestation of a live 
singleton pregnancy who underwent a 50 g OGCT at the Health Sciences University Gazi Yaşargil Training and Research Hos-
pital, between September 2016 and August 2017. In the 50 g OGCT, 1-hour blood glucose results were divided into Low OGCT  
(< 90 mg/dL) and Normal OGCT (90–139 mg/dL). The groups were compared in respect of obstetrics and neonatal outcomes.
Results: Of 2623 pregnant patients applied with the 50 g OGCT, blood glucose was < 140 mg/dL in 77.16% (n = 2024), with 
11.9% (n = 312) in the Low OGCT group, and the remaining 65.26% (n = 1712) in the Normal OGCT group. Based on the 
comparison of the groups, the SGA rate was 7% in the Low OGCT group and 4% in the Normal OGCT group; the 5th minute 
APGAR score was < 7 in 2% of the Low OGCT group and in 1% of the Normal OGCT group, while caesarean section rates 
were 25% and 32% respectively (p < 0.05).
Conclusions: The results of the study showed a significant association between maternal hypoglycaemia and increased 
SGA rate, decreased 5-minute APGAR scores and reduced caesarean section rates, and this relationship should be confirmed 
with further comprehensive studies.
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INTRODUCTION
Gestational diabetes mellitus (GDM) is one of the major 
complications of pregnancy affecting approximately 2–5% 
of pregnancies and resulting in negative pregnancy results 
(including fetal macrosomia, shoulder dystocia, polyhy-
dramnios, operative delivery, preeclampsia, increased cae-
sarean rates and poor neonatal outcomes) [1–2]. Negative 
pregnancy outcomes in GDM have been associated with ma-
ternal hyperglycaemia [3]. Thus, it is important to prevent the 
development of complications by establishing early diagnosis 
and controlling the maternal hyperglycaemia. Therefore, The 
American College of Obstetricians and Gynecologists recom-
mends screening of GDM in all pregnancies [4]. 
While GDM screening has been performed at 24–28 ges-
tational weeks using 50 g OGCT for a long time in many 
centres [5], it has recently been performed alternatively 
using a 75 g oral glucose tolerance test (OGTT) in some 
centres [6]. The test is considered normal when the 1-hour 
blood glucose is < 140 mg/dL after the 50g OGCT, while 
a result between 140–199 mg/dL is considered increased 
and a 75 g or 100 g OGTT is then recommended. When the 
blood glucose level is > 200 mg/dL, it is accepted as GDM [7]. 
Although complications due to maternal hyperglycae-
mia in GDM pregnancies are well known [2], complications 
due to maternal hypoglycaemia are not well known. Two re-
cent studies have reported that hypoglycaemic pregnancies 
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have a higher rate of low birth weight compared with nor-
moglycaemic patients [8–9] while another study has stated 
no difference in these results [10]. Therefore, there remains 
confusion on this subject. 
Objectives
The aim of this study was to compare the obstetrics and ne-
onatal outcomes in pregnant patients with low blood glucose 
levels (< 90 mg/dL) and those with normal blood glucose levels 
(90–139 mg/dL) with the administration of the 50 g OGCT.
MATERIAL AND METHODS
Approval for this retrospective study was granted by 
the Local Ethics Committee. The patients included were 24–
28 weeks pregnant with a live singleton gestation, who were 
administered the 50 g OGCT in the Health Sciences University 
Gazi Yaşargil Training and Research Hospital between Septem-
ber 2016 and August 2017. Information about the pregnancies 
was obtained by reviewing the hospital medical records. In all 
cases, obstetric ultrasound (OB-USG) was performed before 
OGCT. The gestational week was determined by compar-
ing the OB-USG results with the last menstrual period and 
the first trimester OB-USG result. The patients with a blood 
glucose value < 140 mg/dL 1 hour after the 50 g OGCT were 
considered normal, and a 100 g OGTT was applied to patients 
with a value of 140–199 mg/dL. Those with a blood glucose 
level of ≥ 200 mg/dL were considered as GDM. In patients 
submitted to 100 g OGTT, the GDM diagnosis was established 
for those with two or more high blood glucose values from 
four results (fasting blood glucose level: 95 mg/dL, 1st hour 
180 mg/dL, 2nd hour 155 mg/dL and 3rd hour 140 mg/dL) 
according to the Carpenter-Coustan Conversion criteria [11]. 
In the 50 g OGCT, the 1-hour blood glucose results were 
divided into Low OGCT (< 90 mg/dL) and Normal OGCT (90–
139 mg/dL). These two groups were compared in respect 
of obstetrics and neonatal outcomes. The groups were also 
compared in terms of age, gravida, parity, weight gain in preg-
nancy, chronic maternal hypertension, pregnancy-induced 
hypertension (PIH), type of delivery (vaginal or caesarean de-
livery), reasons for caesarean delivery, gestational age, birth 
weight, 5-minute APGAR, 5-minute APGAR < 7, preterm birth 
(< 37 gestation weeks), post term birth (> 42 gestation weeks), 
and small for gestational age (SGA) and newborns defined as 
birth weight < 10th percentile according to the gestational 
age (13). Multiple pregnancies, patients with a Diabetes Melli-
tus diagnosis before the pregnancy, pregnancies with chronic 
disease (asthma, corticosteroid use and chronic hypertension) 
and known foetal anomalies were not included in the study.
Statistical Evaluation
All data analyses were performed using SPSS (Statisti-
cal Package for Social Sciences) version 18.0 for Windows 
software. Normally distributed numerical variables were 
shown as mean ± standard deviation. Normally distributed 
numerical variables were compared using the Student’s 
T-test. The Chi-square test was used to compare categori-
cal variables between the groups. A value of p < 0.05 was 
considered statistically significant.
RESULTS
The study included 2623 pregnant women at 24–28 ges-
tational weeks who underwent 50 g OGCT for GDM screen-
ing between September 2016 and August 2017. The GDM 
screening results of the cases are summarized in Figure 1. 
Normal (< 140 mg /dL)
n = 2024 (% 77.16)
Low (< 90 mg/dL)
n = 312 (% 11.9)
Normal (90–139 mg/dL)
n = 1712 (% 65.26)
High (140–199 mg/dL)





n = 126 (% 4.80)
GDM (≥ 200 mg/dL)
n = 44 (% 1.67)
100 g OGTT
Normal n = 473
(% 18.03)
GDM
n = 82 (% 3.12)
Figure 1. 50 g oral glucose challenge and 100 g oral glucose tolerance test results
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Following the 50 g OGCT, 77.16% (n = 2024) of the patients 
were determined with a normal 1-hour blood glucose level 
(< 140 mg/dL), with 11.9% (n = 312) in the Low OGCT group, 
and the remaining 65.26% (n = 1712) in the Normal OGCT 
group. Of the 21.15% (n = 555) of patients with a 1-hour 
blood glucose level of 140–199 mg/dL, 18.03% (n = 473) 
had a normal 100 g OGTT result and 3.12% (n = 82) were 
diagnosed with GDM. In 1.67% (n = 44) of the patients, the 
1-hour blood glucose level was determined as ≥ 200 mg/dL 
and these patients were diagnosed with GDM without re-
quiring any other evaluation. As a result of the 50 g OGCT 
and 100 g OGTT, a total of 126 (4.80%) patients were diag-
nosed with GDM. The clinical characteristics according to 
the 50 g OGCT are summarized in Table 1. When comparing 
the groups, Group 1 and Group 2 presented the following 
results respectively; average maternal age 26.82 ± 5.7 and 
26.54 ± 5.3 years, multiparity 73% and 72%, primiparity 27% 
and 28%, weight gain in pregnancy 11.1 + 4.1 and 11.1 + 4.06, 
birth weight 3233 ± 483 and 3226 ± 376 g, preterm birth 6% 
and 6%, term birth 87% and 86%, post term birth 7% and 8%, 
maternal chronic hypertension 1.9% and 1.8%, PIH 5% and 6% 
and no statistically significant differences were determined 
(p > 0.05). For the remaining characteristics, Group 1 and 
Group 2 presented the following results respectively; aver-
age rate of vaginal delivery 75% and 68%, caesarean section 
25% and 32%, 5-minute APGAR 9.02 ± 0.96 and 9.26 ± 0.52, 
5-minute APGAR < 7, 2% and 1%, SGA 7% and 4% and the 
differences in these parameters were determined to be 
statistically significant (p < 0.05).The distribution of reasons 
for caesarean section in the Low and Normal OGCT groups 
are summarized in Table 2. When the groups were compared 
in respect of reasons for caesarean delivery, Group 1 and 
Group 2 presented the following results respectively; previous 
caesarean 14% and 16%, abnormal presentation 2% and 2%, 
pregnancy-induced hypertension 1.9% and 2.3%, umbilical 
cord prolapse 0.3% and 0.3%, abnormal placentation 0.6% 
and 0.7%, other fetal and maternal reasons 0.3% and 0.5% 
and no statistically significant differences were determined 
(p > 0.05). For the remaining reasons for caesarean section, 
Group 1 and Group 2 presented the following results respec-
tively; obstructed labor 1% and 4%, cephalopelvic dispropor-
tion 2% and 5%, suspected fetal distress 3 % and 1% and 
the differences in these parameters were determined to be 
statistically significant (p < 0.05).
DISCUSSION
Studies in literature have provided conflicting results in 
respect of maternal hypoglycaemia and negative pregnancy 
outcomes. While some studies have reported no negative 
effects of maternal hypoglycaemia on pregnancies [8–9], 
others have shown an association with negative pregnancy 
outcomes [9, 13–14]. The results of the current study showed 
that maternal hypoglycaemia has negative effects on preg-
nancy outcomes (including increased SGA rates and 5-min-
ute APGAR scores < 7) and these results are similar to the 
findings reported by Shinora et al. [9] and Kwon et al. [14].




(n = 1712)  p-value
Age (years), [mean ± SD] 26.82 ± 5.7 26.54 ± 5.3 0.398*
Multiparity, % (n) 73% (227) 72% (1232) 0.799
Primiparity, % (n) 27% (85) 28% (480) 0.774
Weight gain in pregnacy, kg, (mean ± SD) 11.1 ± 4.1 11.1 + 4.06 0.957
Vaginal delivery, % (n) 75% (234) 68% (1165) 0.015*
Caesarean section, % (n) 25% (78) 32% (547) 0.015*
Gestational age (weeks), [mean] 39.1 ± 1.74 38.9 ± 1.58 0.043*
Birth weight (gr), [mean ± SD] 3233 ± 483 3226 ± 376 0.793
5-minute APGAR [median(min-max)]   9.02 ± 0.96 9.26 ± 0.52 0.001*
5-minute APGAR < 7 (n) 2 % (7) 1% (14) 0.020*
Preterm birth, % (n) 6 % (19) 6 % (102) 0.928
Term birth, % (n) 87 % (271) 86 % (1512) 0.720
Postterm birth, % (n) 7 % (22) 8 % (136) 0.589
SGA, % (n) 7 % (22) 4% (68) 0.015*
Chronic maternal HT, % (n) 2% (6) 2% (31) 0.892
PIH, % (n) 5 % (16) 6 % (98) 0.675
Values are presented as mean ± standard deviation or number (%); OGCT — oral glucose challenge test; SGA — small for gestational age; PIH — pregnancy-induced 
hypertension; HT — hypertension *Chi-Square p < 0.05
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Shinora et al reported SGA ratios of 15.3% in the Low 
OGCT group (≤ 90 mg/dL) and of 9.7% in the Normal OGCT 
group (91–139 mg/dL) [9], while Kwon et al reported SGA 
ratios of 10.8% in the Low OGCT group (≤ 85 mg/dL) and of 
7.9% in the Normal OGCT group (86–130 mg/dL) (14). Both 
of these studies reported that the difference between the 
groups was statistically significant. However, in a study by 
Ma et al, SGA ratios were reported to be 9% in the Low OGCT 
group (< 90 mg/dL) and 4.8% in the Normal OGCT group 
(90–119 mg/dL), with no statistically significant difference 
determined [10]. In the current study, the SGA ratios were 7% 
in the Low OGCT group and 4% in the Normal OGCT group, 
and this difference was found to be statistically significant, in 
agreement with the studies of Shinora et al. [9] and Kwon et 
al. [14]. However, the SGA ratios in both groups in the current 
study were found to be lower than the ratios in those three 
studies. In a previous animal experimental study, maternal 
hypoglycemia during pregnancy was associated with a de-
crease in fetal glucose, an increase in protein breakdown, 
and increased oxidative metabolism [15]. These factors were 
considered to have contributed to high SGA rates in the preg-
nancies with hypoglycemia in the current study.
In a study by Feinberg et al., a 5-minute APGAR 
score < 7 was determined in 1.7% of the Low OGCT group 
(< 88 mg/dL) and in 0.8% of the Normal OGCT group (88–
–140 mg/dL) respectively, but this difference between the 
groups was not found to be statistically significant [16]. In 
contrast, these ratios in the current study were 2% and 1%, 
respectively, and the difference was were statistically signifi-
cant. It was thought that the high rate of APGAR score < 7 in 
the Low OGCT group of the current study may have been re-
lated to the elevated SGA infant ratio. McIntire et al. showed 
that APGAR score is significantly lower in SGA infants [17].
Shinora et al. [9] reported caesarean section delivery at 
a rate of 18.8% in the Low OGCT group and 25.7% in the 
Normal OGCT group, whereas Kwon et al reported these 
rates as 32.6% and 42.8%, respectively [14]. Both researchers 
reported that the difference between the groups was statisti-
cally significant. However no statistically significant difference 
was seen in a study by Ma et al. with these ratios reported 
as 24.1% and 24.9%, respectively (10). In the current study, 
caesarean section rates were 25% in the Low OGCT group and 
32% in the Normal OGCT group, and this difference was found 
to be statistically significant, which was consistent with the 
studies of Shinora et al. [9] and Kwon et al. [14]. In the current 
study, caesarean rates due to fetal distress were found to be 
significantly higher in the Low OGCT group compared to the 
Normal OGCT group, which could have been due to the high 
rate of SGA in the Low OGCT group. However, in the Normal 
OGCT group, the rates of caesarean delivery performed be-
cause of obstructed labor and cephalopelvic disproportion 
were significantly higher than those of the Low OGCT group. 
In addition to these results, there were no statistically signifi-
cant differences between the two groups in respect of other 
reasons for caesarean delivery, such as previous caesarean, 
abnormal presentation, pregnancy-induced hypertension, 
umbilical cord prolapse, abnormal placentation and other 
fetal-maternal reasons.
A significant difference from previous studies was seen 
in the current study in respect of gestational age, while 
weight gain in pregnancy, birth weight, preterm birth, term 
birth, post term birth and PIH results were not significant 
and similar to previous findings in literature [9, 10, 14].
The maternal chronic hypertension rates of the groups 
in the current study were found to be 1.9% and 1.8%, similar 
to those in literature [18–19] and there was no significant dif-
ference in maternal hypertension rates between the groups.
In conclusion, the results of this study showed a sig-
nificant association between maternal hypoglycaemia and 
increased SGA rate, decreased 5-minute APGAR scores 
and reduced caesarean section rates, and this relationship 
should be confirmed with further comprehensive studies.




(n = 1712) p-value
Previous caesarean, % (n) 14% (44) 16% (275) 0.382
Obstructed labor, % (n) 1% (3) 4%(69) 0.007
Cephalopelvic disproportion, % (n) 2% (6) 5%(86) 0.016
Suspected fetal distress, % (n) 3% (9) 1% (17) 0.012
Abnormal presentation, % (n) 2% (6) 2% (32) 0.949
Pregnancy-induced hypertension, % (n) 1.9% (6) 2.3% (40) 0.652
Umbilical cord prolapse, % (n) 0.3% (1) 0.3 %(6) 1,000
Abnormal placentation, % (n) 0.6% (2) 0.7% (13) 1,000
Other fetal and maternal reasons, % (n) 0.3% (1) 0.5% (9) 1,000
OGCT — oral glucose challenge test
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